Skip to main content
Erschienen in: Pediatric Surgery International 3/2014

01.03.2014 | Original Article

The effect of vascular endothelial growth factor overexpression in experimental necrotizing enterocolitis

verfasst von: Hande Ozgun Karatepe, Huseyin Kilincaslan, Mustafa Berber, Ahmet Ozen, Hulya Ercan Saricoban, Duran Ustek, Ahu Sarbay Kemik, Mine Adas, Filiz Bakar

Erschienen in: Pediatric Surgery International | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Necrotizing enterocolitis (NEC) is a serious condition, predominantly observed in premature infants. We used an experimental NEC model to investigate the effects of vascular endothelial growth factor (VEGF) cloned into a plasmid.

Materials and methods

Twenty-four newborn Wistar albino rats were randomized equally into three groups as follows: control, NEC and NEC+VEGF. NEC was induced by hyperosmolar enteral formula feeding, exposure to hypoxia/reoxygenation and cold stress. In the NEC+VEGF group, VEGF (1 μg) incorporated into plasmid (2 μg) was administered subcutaneously once daily for a total of 3 days starting on the first day of the NEC procedure. All rats were sacrificed on the 4th day of life, and the specimens were harvested for histopathological and biochemical examinations [including tissue oxidative stress (malondialdehyde and nitric oxide), inflammation (myeloperoxidase, interleukin-6 and tumor necrosis factor alpha) and apoptosis (caspase-3 activity) parameters].

Results

In the NEC+VEGF group, tissue malondialdehyde, nitric oxide, interleukin-6, tumor necrosis factor alpha levels and caspase-3 activity were significantly decreased. In addition, the myeloperoxidase level was increased compared to that of the NEC group (p < 0.05). Histopathologically, VEGF overexpression enhanced angiogenesis, alleviated villous atrophy and tissue edema (p < 0.05).

Conclusion

VEGF overexpression with plasmids seems to be a promising approach in the management of NEC.
Literatur
2.
Zurück zum Zitat Hsueh W, Caplan MS, Qu XW, Tan XD, De Plaen IG, Gonzalez-Crussi F (2003) Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 6:6–23PubMedCrossRef Hsueh W, Caplan MS, Qu XW, Tan XD, De Plaen IG, Gonzalez-Crussi F (2003) Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 6:6–23PubMedCrossRef
3.
Zurück zum Zitat Albanese CT, Rowe MI (1998) Necrotizing enterocolitis. In: O’Neill JA Jr, Rowe MI, Grosfeld JL, Fonkalsrud EW, Coran AG (eds) Pediatric surgery, 5th edn. Mosby, St. Louis, pp 1297–1320 Albanese CT, Rowe MI (1998) Necrotizing enterocolitis. In: O’Neill JA Jr, Rowe MI, Grosfeld JL, Fonkalsrud EW, Coran AG (eds) Pediatric surgery, 5th edn. Mosby, St. Louis, pp 1297–1320
4.
Zurück zum Zitat Noerr B (2003) Current controversies in the understanding of necrotizingenterocolitis. Part 1. Adv Neonatal Care 3:107–120PubMedCrossRef Noerr B (2003) Current controversies in the understanding of necrotizingenterocolitis. Part 1. Adv Neonatal Care 3:107–120PubMedCrossRef
5.
Zurück zum Zitat Koruda MJ, Rolandelli RH (1990) Experimental studies on the healing of colonic anastomoses. J Surg Res 48:504–515PubMedCrossRef Koruda MJ, Rolandelli RH (1990) Experimental studies on the healing of colonic anastomoses. J Surg Res 48:504–515PubMedCrossRef
6.
Zurück zum Zitat Thyoka M, de Coppi P, Eaton S, Khoo K, Hall NJ, Curry J, Kiely E, Drake D, Cross K, Pierro A (2012) Advanced necrotizing enterocolitis part 1: mortality. Eur J Pediatr Surg 22:8–12PubMedCrossRef Thyoka M, de Coppi P, Eaton S, Khoo K, Hall NJ, Curry J, Kiely E, Drake D, Cross K, Pierro A (2012) Advanced necrotizing enterocolitis part 1: mortality. Eur J Pediatr Surg 22:8–12PubMedCrossRef
7.
Zurück zum Zitat Nadler EP, Dickinson E, Knisely A, Zhang XR, Boyle P, Beer-Stolz D, Watkins SC, Ford HR (2000) Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis. J Surg Res 92:71–77PubMedCrossRef Nadler EP, Dickinson E, Knisely A, Zhang XR, Boyle P, Beer-Stolz D, Watkins SC, Ford HR (2000) Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis. J Surg Res 92:71–77PubMedCrossRef
8.
Zurück zum Zitat Yurdakok B, Canpolat FE, Orhan D, Kale G (2010) Effects of enteral insulin on hypoxic changes in a rat model of necrotizing enterocolitis. Indian Pediatr 47:887–888PubMedCrossRef Yurdakok B, Canpolat FE, Orhan D, Kale G (2010) Effects of enteral insulin on hypoxic changes in a rat model of necrotizing enterocolitis. Indian Pediatr 47:887–888PubMedCrossRef
9.
Zurück zum Zitat Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 47:298–307 (Review)CrossRef Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 47:298–307 (Review)CrossRef
10.
Zurück zum Zitat Moore TC, Collins DL, Nguyen M (2002) Marked (24-fold) elevation of peritoneal cavity drainage fluid vascular endothelial growth factor after successful “patch, drain, and wait” approach for extensive midgut necrosis in a newborn. Pediatr Surg Int 18:400–404PubMedCrossRef Moore TC, Collins DL, Nguyen M (2002) Marked (24-fold) elevation of peritoneal cavity drainage fluid vascular endothelial growth factor after successful “patch, drain, and wait” approach for extensive midgut necrosis in a newborn. Pediatr Surg Int 18:400–404PubMedCrossRef
11.
Zurück zum Zitat Maynard AA, Dvorak K, Khailova L, Dobrenen H, Arganbright KM, Halpern MD, Kurundkar AR, Maheshwari A, Dvorak B (2010) Epidermal growth factor reduces autophagy in intestinal epithelium and in the rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 299:G614–G622PubMedCrossRef Maynard AA, Dvorak K, Khailova L, Dobrenen H, Arganbright KM, Halpern MD, Kurundkar AR, Maheshwari A, Dvorak B (2010) Epidermal growth factor reduces autophagy in intestinal epithelium and in the rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 299:G614–G622PubMedCrossRef
12.
Zurück zum Zitat Wu SF, Caplan M, Lin HC (2012) Necrotizing enterocolitis: old problem with new hope. Pediatr Neonatol 53(3):158–163PubMedCrossRef Wu SF, Caplan M, Lin HC (2012) Necrotizing enterocolitis: old problem with new hope. Pediatr Neonatol 53(3):158–163PubMedCrossRef
13.
Zurück zum Zitat van Montfrans C, te Velde AA, van Deventer SJ, Rodriguez Pena MS (2004) Gene therapy in the treatment of intestinal inflammation. Int J Colorectal Dis 19:79–86 (Review)PubMedCrossRef van Montfrans C, te Velde AA, van Deventer SJ, Rodriguez Pena MS (2004) Gene therapy in the treatment of intestinal inflammation. Int J Colorectal Dis 19:79–86 (Review)PubMedCrossRef
14.
Zurück zum Zitat Giacca M (2007) Virus-mediated gene transfer to induce therapeutic angiogenesis: where do we stand? Int J Nanomedicine 2(4):527–540 (Review)PubMedCentralPubMed Giacca M (2007) Virus-mediated gene transfer to induce therapeutic angiogenesis: where do we stand? Int J Nanomedicine 2(4):527–540 (Review)PubMedCentralPubMed
15.
Zurück zum Zitat Hunter CJ, Upperman JS, Ford HR, Camerini V (2008) Understanding the susceptibility of the premature infant to necrotizing enterocolitis (NEC). Pediatr Res 63:117–123 (Review)PubMedCrossRef Hunter CJ, Upperman JS, Ford HR, Camerini V (2008) Understanding the susceptibility of the premature infant to necrotizing enterocolitis (NEC). Pediatr Res 63:117–123 (Review)PubMedCrossRef
16.
Zurück zum Zitat Rowland KJ, Choi PM, Warner BW (2013) The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis. Semin Pediatr Surg 22(2):101–111 (Review)PubMedCrossRef Rowland KJ, Choi PM, Warner BW (2013) The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis. Semin Pediatr Surg 22(2):101–111 (Review)PubMedCrossRef
17.
Zurück zum Zitat Downard CD, Renaud E, St Peter SD, Abdullah F, Islam S, Saito JM, Blakely ML, Huang EY, Arca MJ, Cassidy L, Aspelund G (2012) Treatment of necrotizing enterocolitis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg 47(11):2111–2122 (Review)PubMedCrossRef Downard CD, Renaud E, St Peter SD, Abdullah F, Islam S, Saito JM, Blakely ML, Huang EY, Arca MJ, Cassidy L, Aspelund G (2012) Treatment of necrotizing enterocolitis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg 47(11):2111–2122 (Review)PubMedCrossRef
18.
Zurück zum Zitat Patil SD, Rhodes DG, Burgess DJ (2005) DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J 7:E61–E77 (Review)PubMedCrossRef Patil SD, Rhodes DG, Burgess DJ (2005) DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J 7:E61–E77 (Review)PubMedCrossRef
19.
Zurück zum Zitat Scotland G, Beard M, Erdogan S, Huston E, McCallum F, MacKenzie SJ, Peden AH, Pooley L, Rena NG, Ross AH, Yarwood SJ, Houslay MD (1998) Intracellular compartmentalization of PDE4 cyclic AMP-specific phosphodiesterases. Methods 14(1):65–79PubMedCrossRef Scotland G, Beard M, Erdogan S, Huston E, McCallum F, MacKenzie SJ, Peden AH, Pooley L, Rena NG, Ross AH, Yarwood SJ, Houslay MD (1998) Intracellular compartmentalization of PDE4 cyclic AMP-specific phosphodiesterases. Methods 14(1):65–79PubMedCrossRef
20.
Zurück zum Zitat Guven A, Gundogdu G, Vurucu S, Uysal B, Oztas E, Ozturk H, Korkmaz A (2009) Medical ozone therapy reduces oxidative stress and intestinal damage in an experimental model of necrotizing enterocolitis in neonatal rats. J Pediatr Surg 44:1730–1735PubMedCrossRef Guven A, Gundogdu G, Vurucu S, Uysal B, Oztas E, Ozturk H, Korkmaz A (2009) Medical ozone therapy reduces oxidative stress and intestinal damage in an experimental model of necrotizing enterocolitis in neonatal rats. J Pediatr Surg 44:1730–1735PubMedCrossRef
21.
Zurück zum Zitat Uchiyama M, Mihars M (1978) Determination of malondialdehyde precursor in tissues by thiobarbituric acid. Ann Biochem 86:271–278CrossRef Uchiyama M, Mihars M (1978) Determination of malondialdehyde precursor in tissues by thiobarbituric acid. Ann Biochem 86:271–278CrossRef
22.
Zurück zum Zitat Moshage H (2009) Simple and reliable measurement of nitric oxide metabolites in plasma. Clin Chem 55:1881–1882PubMedCrossRef Moshage H (2009) Simple and reliable measurement of nitric oxide metabolites in plasma. Clin Chem 55:1881–1882PubMedCrossRef
23.
Zurück zum Zitat Kruidenier L, Kuiper I, Van Duijn W, Mieremet-Ooms MA, van Hogezand RA, Lamers CB, Verspaget HW (2003) Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol 201(1):17–27PubMedCrossRef Kruidenier L, Kuiper I, Van Duijn W, Mieremet-Ooms MA, van Hogezand RA, Lamers CB, Verspaget HW (2003) Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol 201(1):17–27PubMedCrossRef
24.
Zurück zum Zitat Jonges LE, Nagelkerke JF, Ensink NG, van der Velde EA, Tollenaar RA, Fleuren GJ, van de Velde CJ, Morreau H, Kuppen PJ (2001) Caspase-3 activity as a prognostic factor in colorectal carcinoma. Lab Invest 81(5):681–688PubMedCrossRef Jonges LE, Nagelkerke JF, Ensink NG, van der Velde EA, Tollenaar RA, Fleuren GJ, van de Velde CJ, Morreau H, Kuppen PJ (2001) Caspase-3 activity as a prognostic factor in colorectal carcinoma. Lab Invest 81(5):681–688PubMedCrossRef
25.
Zurück zum Zitat Adas G, Percem A, Adas M, Kemik O, Arikan S, Ustek D, Cakiris A, Abaci N, Kemik AS, Kamali G, Karahan S, Akcakaya A, Karatepe O (2011) VEGF-A and FGF gene therapy accelerate healing of ischemic colonic anastomoses (experimental study). Int J Surg 9:467–471PubMedCrossRef Adas G, Percem A, Adas M, Kemik O, Arikan S, Ustek D, Cakiris A, Abaci N, Kemik AS, Kamali G, Karahan S, Akcakaya A, Karatepe O (2011) VEGF-A and FGF gene therapy accelerate healing of ischemic colonic anastomoses (experimental study). Int J Surg 9:467–471PubMedCrossRef
26.
Zurück zum Zitat Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M (2008) Growth factors and cytokines in wound healing. Wound Repair Regen 16:585–601PubMedCrossRef Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M (2008) Growth factors and cytokines in wound healing. Wound Repair Regen 16:585–601PubMedCrossRef
27.
Zurück zum Zitat Bányász I, Bokodi G, Vásárhelyi B, Treszl A, Derzbach L, Szabó A, Tulassay T, Vannay A (2006) Genetic polymorphisms for vascular endothelial growth factor in perinatal complications. Eur Cytokine Netw 17:266–270PubMed Bányász I, Bokodi G, Vásárhelyi B, Treszl A, Derzbach L, Szabó A, Tulassay T, Vannay A (2006) Genetic polymorphisms for vascular endothelial growth factor in perinatal complications. Eur Cytokine Netw 17:266–270PubMed
Metadaten
Titel
The effect of vascular endothelial growth factor overexpression in experimental necrotizing enterocolitis
verfasst von
Hande Ozgun Karatepe
Huseyin Kilincaslan
Mustafa Berber
Ahmet Ozen
Hulya Ercan Saricoban
Duran Ustek
Ahu Sarbay Kemik
Mine Adas
Filiz Bakar
Publikationsdatum
01.03.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Surgery International / Ausgabe 3/2014
Print ISSN: 0179-0358
Elektronische ISSN: 1437-9813
DOI
https://doi.org/10.1007/s00383-013-3460-z

Weitere Artikel der Ausgabe 3/2014

Pediatric Surgery International 3/2014 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.